CA97063/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2002	1
2003	4
2004	3
2005	2
2006	2
2007	5
2008	2
2024	0

1

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW, Varambally S, Cao X, Tchinda J, Kuefer R, Lee C, Montie JE, Shah RB, Pienta KJ, Rubin MA, Chinnaiyan AM. Tomlins SA, et al. Science. 2005 Oct 28;310(5748):644-8. doi: 10.1126/science.1117679. Science. 2005. PMID: 16254181

2

Prostate cancer biomarkers: a current perspective.

Kumar-Sinha C, Rhodes DR, Yu J, Chinnaiyan AM. Kumar-Sinha C, et al. Expert Rev Mol Diagn. 2003 Jul;3(4):459-70. doi: 10.1586/14737159.3.4.459. Expert Rev Mol Diagn. 2003. PMID: 12877385 Review.

3

Molecular markers to identify patients at risk for recurrence after primary treatment for prostate cancer.

Kumar-Sinha C, Chinnaiyan AM. Kumar-Sinha C, et al. Urology. 2003 Dec 29;62 Suppl 1:19-35. doi: 10.1016/j.urology.2003.10.007. Urology. 2003. PMID: 14747039 Review.

4

Molecular markers of prostate cancer.

Bradford TJ, Tomlins SA, Wang X, Chinnaiyan AM. Bradford TJ, et al. Urol Oncol. 2006 Nov-Dec;24(6):538-51. doi: 10.1016/j.urolonc.2006.07.004. Urol Oncol. 2006. PMID: 17138135 Review.

5

Protein microarrays: a powerful tool to study cancer.

Sreekumar A, Chinnaiyan AM. Sreekumar A, et al. Curr Opin Mol Ther. 2002 Dec;4(6):587-93. Curr Opin Mol Ther. 2002. PMID: 12596361 Review.

6

The lethal phenotype of cancer: the molecular basis of death due to malignancy.

Loberg RD, Bradley DA, Tomlins SA, Chinnaiyan AM, Pienta KJ. Loberg RD, et al. CA Cancer J Clin. 2007 Jul-Aug;57(4):225-41. doi: 10.3322/canjclin.57.4.225. CA Cancer J Clin. 2007. PMID: 17626119 Free article. Review.

7

Integrative analysis of genomic aberrations associated with prostate cancer progression.

Kim JH, Dhanasekaran SM, Mehra R, Tomlins SA, Gu W, Yu J, Kumar-Sinha C, Cao X, Dash A, Wang L, Ghosh D, Shedden K, Montie JE, Rubin MA, Pienta KJ, Shah RB, Chinnaiyan AM. Kim JH, et al. Cancer Res. 2007 Sep 1;67(17):8229-39. doi: 10.1158/0008-5472.CAN-07-1297. Cancer Res. 2007. PMID: 17804737

8

A polycomb repression signature in metastatic prostate cancer predicts cancer outcome.

Yu J, Yu J, Rhodes DR, Tomlins SA, Cao X, Chen G, Mehra R, Wang X, Ghosh D, Shah RB, Varambally S, Pienta KJ, Chinnaiyan AM. Yu J, et al. Cancer Res. 2007 Nov 15;67(22):10657-63. doi: 10.1158/0008-5472.CAN-07-2498. Cancer Res. 2007. PMID: 18006806

9

EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells.

Kleer CG, Cao Q, Varambally S, Shen R, Ota I, Tomlins SA, Ghosh D, Sewalt RG, Otte AP, Hayes DF, Sabel MS, Livant D, Weiss SJ, Rubin MA, Chinnaiyan AM. Kleer CG, et al. Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11606-11. doi: 10.1073/pnas.1933744100. Epub 2003 Sep 19. Proc Natl Acad Sci U S A. 2003. PMID: 14500907 Free PMC article.

10

Identification of two molecular groups of seminomas by using expression and tissue microarrays.

Hofer MD, Browne TJ, He L, Skotheim RI, Lothe RA, Rubin MA. Hofer MD, et al. Clin Cancer Res. 2005 Aug 15;11(16):5722-9. doi: 10.1158/1078-0432.CCR-05-0533. Clin Cancer Res. 2005. PMID: 16115909

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Results by year